Nyxoah S.A. (NYXH)
NASDAQ: NYXH · Real-Time Price · USD
8.01
+0.01 (0.13%)
Dec 20, 2024, 4:00 PM EST - Market closed

Nyxoah Revenue

Nyxoah had revenue of 1.27M EUR in the quarter ending September 30, 2024, with 29.71% growth. This brings the company's revenue in the last twelve months to 5.08M, up 32.65% year-over-year. In the year 2023, Nyxoah had annual revenue of 4.35M with 40.99% growth.

Revenue (ttm)
5.08M EUR
Revenue Growth
+32.65%
P/S Ratio
n/a
Revenue / Employee
34,619 EUR
Employees
147
Market Cap
303.79M USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20234.35M1.26M40.99%
Dec 31, 20223.08M2.23M261.97%
Dec 31, 2021852.00K783.00K1,134.78%
Dec 31, 202069.00K--
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Viemed Healthcare 214.30M
Canopy Growth 207.63M
AirSculpt Technologies 188.78M
Rigel Pharmaceuticals 157.37M
Sanara MedTech 78.06M
AVITA Medical 60.04M
Immutep 2.56M
Sera Prognostics 94.00K
Revenue Rankings